License from Synaffix focuses on bispecific ADCs This close collaboration between ABL Bio and Synaffix provides optimal conditions to accelerate research and development of resulting next-generation bioconjugates AMSTERDAM, Sept. 13, 2023 /PRNewswire/ — Synaffix B.V., a Lonza company…